The recently published OZAVIE observational study confirms that the combination of ceftazidime and avibactam (CAZ-AVI) is effective, with a clinical success rate ranging from 63.4% to 79% in the treatment of multidrug-resistant Gram-negative (MDR-GNB) infections. These rates increase from 65.6% ...